eLife today announces that Jeff Settleman, Head of Oncology Research at Calico Life Sciences LLC, has joined the open-access journal as Senior Editor for Cancer Biology. A specialist in molecularly targeted cancer therapeutics and personalised cancer medicine, Settleman will work with other Senior Editors, primarily Charles Sawyers (Memorial Sloan Kettering) and Sean Morrison (UT Southwestern Medical Centre), and a team of Reviewing Editors in the journal’s bid to help accelerate discovery within cancer research.
Jeff Settleman.
Established by the Howard Hughes Medical Institute (USA), Max Planck Society (Germany) and Wellcome (UK) – and now backed by the Knut and Alice Wallenberg Foundation (Sweden) – eLife has a mission to help scientists take research forward more efficiently by operating a platform for research communication that encourages and recognises the most responsible behaviours in science.
eLife is best known for its collaborative approach to peer review: referees discuss reports openly with one another before taking a decision, and authors are sent a single decision letter that explains the revisions they need to make to have their paper accepted. The journal aims to publish work of the highest standards in all areas of the life and biomedical sciences, including conceptually important advances in all areas of cancer biology. eLife is also a partner in the Reproducibility Project: Cancer Biology, an initiative to independently replicate selected results from a number of high-profile papers in the field.
After receiving his PhD in Genetics from Yale University in 1989, Settleman continued his career in academia until 2010, when he joined Genentech as the Senior Director of Discovery Oncology. His role involved overseeing efforts to identify and validate targets for oncology drug discovery and to discover predictive biomarkers for new cancer therapies. He later joined CalicoLabs as Head of Oncology Research in April 2015.
“I’ve had a number of opportunities to collaborate with eLife and I’m convinced that they have developed an exemplary model for improving the peer-review process,” said Settleman. “I look forward to working with my colleagues on the board to expand the impact of the journal in cancer research and in the translation of advances in basic biological research into new treatments.” Settleman was a co-author of ‘Science Forum: Challenges in validating candidate therapeutic targets in cancer’, published in eLife earlier this year.
“Jeff helped eLife tremendously as a member of our Board of Reviewing Editors. We’re enthusiastic that his new responsibilities will boost our exposure to cancer biologists and we are pleased to welcome him as a Senior Editor,” added Randy Schekman, eLife Editor-in-Chief and professor of molecular and cell biology at the University of California, Berkeley.
Dr. Settleman’s biography is available on the eLife website at https://elifesciences.org/about/people/cancer-biology
To learn more about what eLife publishes in Cancer Biology, visit https://elifesciences.org/subjects/cancer-biology
For more information about the Reproducibility Project: Cancer Biology, visit https://elifesci.org/reproducibility-project
Media contacts
Emily Packer
eLife
e.packer@elifesciences.org
+441223855373
About
eLife aims to help scientists accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours in science. We publish important research in all areas of the life and biomedical sciences, which is selected and evaluated by working scientists and made freely available online without delay. eLife also invests in innovation through open-source tool development to accelerate research communication and discovery. Our work is guided by the communities we serve. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, the Wellcome Trust and the Knut and Alice Wallenberg Foundation. Learn more at https://elifesciences.org/about.
